http://www.fpnotebook.com/
Hib VaccineAka: Haemophilus influenzae B Vaccine
- Mechanism
- Conjugated protein vaccine
- Preparations
- HIBTITER (HbOC)
- PedvaxHIB (PRP-OMP)
- ActHIB (PRP-T)
- Primary Series
- Dose 1: Age 2 months
- Dose 2: Age 4 months
- Dose 3: Age 6 months
- Dose 4: Age 12 to 15 months
- Adverse Effects
- No serious side effects
- References
Haemophilus influenzae type b polysaccharide vaccine (C0062086) | |
|---|---|
| Concepts | Carbohydrate (T118) , Pharmacologic Substance (T121) , Immunologic Factor (T129) |
| MSH | C044237 |
| English | Haemophilus influenzae type b polyribosylribitol phosphate capsular polysaccharide vaccine, Haemophilus influenzae type b polysaccharide vaccine, Haemophilus influenzae type b vaccine, Hemophilus influenzae Type b vaccine, HIB - Haemophilus influenzae Type B vaccine, HIB - Hemophilus influenzae Type B vaccine, HIB-vaccine |
| Spanish | vacuna anti-Haemophilus influenzae tipo b |
| Parent Concepts | Bacterial Vaccines (C0004632), Influenza virus vaccine (C0021403), Drug allergen (C1320237), Vaccines (C0042210) |
| Sources | MSH, MTH, SCTSPA, SNOMEDCT Derived from the NIH UMLS (Unified Medical Language System) |
